Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A Novel Level 1 Oncoplastic Technique for Breast Conserving Surgery: The Rhomboid Rotation Glandular Flap.
Journal: Clinical breast cancer
Published: April 02, 2025
Preoperative Axillary Ultrasound in the Era of Z0011: A Model for Predicting High Axillary Disease Burden.
Journal: Current oncology (Toronto, Ont.)
Published: March 03, 2025
Oncoplastic Surgery: Where Are We Now?
Journal: Journal of surgical oncology
Published: March 15, 2024
2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.
Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: April 28, 2022
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
Journal: Annals of surgical oncology
Published: April 04, 2022
Cystic hypersecretory ductal carcinoma (CHDC): a rare distinctive variant of ductal carcinoma.
Journal: BMJ case reports
Published: July 22, 2021
Clinical and patient-reported outcomes in oncoplastic breast conservation surgery from a single surgeon's practice in a busy community hospital in Canada.
Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: February 04, 2021
Title Not Found
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: November 10, 2020
Health care practitioners' responsibility to address intimate partner violence related to the COVID-19 pandemic.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: May 03, 2020
Flat epithelial atypia: are we being too aggressive?
Journal: Breast cancer research and treatment
Published: September 15, 2019
Cases of Early Infectious Flexor Tenosynovitis Treated Non-Surgically With Antibiotics, Immobilization, and Elevation.
Journal: Plastic surgery (Oakville, Ont.)
Published: April 06, 2018
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.
Journal: Leukemia & lymphoma
Published: September 18, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026